FIELD: chemistry.
SUBSTANCE: invention relates to a compoundd represented by the formula
,
its enantiomers, diastereoisomers or pharmaceutically acceptable salts, which have modulatory activity against N-formylpeptide receptor-1 (FPRL-1). In formula II, a is 1, b is 0 or a is 1, b is 1; R1 is -OH; R2 is C1-8 Alkyl, optionally substituted by C6-10 aryl, amide or heterocycle, wherein the heterocycle is a 3 to 10-membered aromatic ring which contains at least one heteroatom selected from nitrogen, wherein one methylene group in the alkyl can be replaced by sulfur or sulphonyl; R3 is hydrogen or halogen; R4 is hydrogen; R5 is a halogen, -CF3 Or -S (O)nR14; N is 0, 1 or 2; R6 is hydrogen; R7 is hydrogen or halogen; R8 is hydrogen or C1-8 Alkyl; R9 is hydrogen, C1-8 Alkyl, Optionally substituted with a hydroxyl group, or C6-10 aryl; R10 is hydrogen, C1-8 alkyl optionally substituted with a hydroxyl group, or C6-10 aryl; R9a is hydrogen or C1-8 alkyl optionally substituted with a hydroxyl group; R10a is hydrogen or C1-8 alkyl optionally substituted with a hydroxyl group; R14 is CF3 or C1-8 alkyl.
EFFECT: increased activity of derivatives.
12 cl, 5 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2663911C2 |
USE OF FORMYL PEPTIDE RECEPTOR 2 AGONISTS FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2768730C2 |
AMIDE DERIVATIVES OF N-CARBAMIDE-SUBSTITUTED AMINO ACIDS AS MODULATORS OF FORMYLPEPTIDE RECEPTOR-1 (FPRL-1) | 2012 |
|
RU2744577C2 |
DERIVATIVES OF 2,5-DIOXOIMIDAZOLIDINE-1-YL-3-PHENYLUREA AS MODULATORS OF FORMYLPEEPTITIDE RECEPTOR 1 (FPRL-1) | 2012 |
|
RU2645673C2 |
PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS | 2014 |
|
RU2703725C1 |
USING FORMYLPEPTIDE RECEPTOR 2 AGONISTS FOR TREATING DERMATOLOGIC DISEASES | 2014 |
|
RU2696487C2 |
DERIVATIVES OF N-UREA-SUBSTITUTED AMINOACIDS AS MODULATORS OF FORMYL-PEPTIDE RECEPTOR | 2014 |
|
RU2696581C2 |
COMPOUNDING, WHICH INHIBITES ACTIVITY OF BTK AND/OR JAK3 KINASES | 2014 |
|
RU2650512C2 |
ANTHELMINTHIC DEPSIPEPTIDE COMPOUNDS | 2016 |
|
RU2715556C2 |
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
Authors
Dates
2017-08-25—Published
2012-10-23—Filed